showed a trendP < 0.057
Mutation-carrying living PPMI PD patients showed a trend of reduction in blood MT-tRF levels compared to unaffected mutation-carrying controls ( P < 0.057, Mann–Whitney, FDR; Fig. 2g ).
Mutation-carrying living PPMI PD patients showed a trend of reduction in blood MT-tRF levels compared to unaffected mutation-carrying controls ( P < 0.057, Mann–Whitney, FDR; Fig. 2g ).